Coverage
-
September 20, 2021
A New Jersey federal judge on Monday adopted a recommendation to dismiss a shareholder derivative class action that alleged executives of Canadian pharmaceutical company Bausch Health Cos. Inc. tried to cover up a price-gouging scheme.
1 other articles on this case.
View all »